157 related articles for article (PubMed ID: 12437507)
1. Treprostinil therapy for pulmonary artery hypertension.
Horn EM; Barst RJ
Expert Opin Investig Drugs; 2002 Nov; 11(11):1615-22. PubMed ID: 12437507
[TBL] [Abstract][Full Text] [Related]
2. Overview of treprostinil sodium for the treatment of pulmonary arterial hypertension.
Budev MM; Minai OA; Arroliga AC
Drugs Today (Barc); 2004 Mar; 40(3):225-34. PubMed ID: 15148531
[TBL] [Abstract][Full Text] [Related]
3. Inhaled treprostinil for the treatment of pulmonary arterial hypertension.
LeVarge BL; Channick RN
Expert Rev Respir Med; 2012 Jun; 6(3):255-65. PubMed ID: 22788940
[TBL] [Abstract][Full Text] [Related]
4. The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension.
Gessler T; Seeger W; Schmehl T
Ther Adv Respir Dis; 2011 Jun; 5(3):195-206. PubMed ID: 21300738
[TBL] [Abstract][Full Text] [Related]
5. Treprostinil for pulmonary hypertension.
Vachiéry JL; Naeije R
Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):183-91. PubMed ID: 15151467
[TBL] [Abstract][Full Text] [Related]
6. The role of treprostinil in the management of pulmonary hypertension.
Skoro-Sajer N; Lang I
Am J Cardiovasc Drugs; 2008; 8(4):213-7. PubMed ID: 18690755
[TBL] [Abstract][Full Text] [Related]
7. Prostanoid therapy for pulmonary arterial hypertension.
Badesch DB; McLaughlin VV; Delcroix M; Vizza CD; Olschewski H; Sitbon O; Barst RJ
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):56S-61S. PubMed ID: 15194179
[TBL] [Abstract][Full Text] [Related]
8. Experiences with treprostinil in the treatment of pulmonary arterial hypertension.
Stream AR; Bull TM
Ther Adv Respir Dis; 2012 Oct; 6(5):269-76. PubMed ID: 22868690
[TBL] [Abstract][Full Text] [Related]
9. Treprostinil for pulmonary hypertension.
Skoro-Sajer N; Lang I; Naeije R
Vasc Health Risk Manag; 2008; 4(3):507-13. PubMed ID: 18827901
[TBL] [Abstract][Full Text] [Related]
10. Treprostinil for the treatment of pulmonary arterial hypertension.
Torres F; Rubin LJ
Expert Rev Cardiovasc Ther; 2013 Jan; 11(1):13-25. PubMed ID: 23259441
[TBL] [Abstract][Full Text] [Related]
11. Oral treprostinil diethanolamine for pulmonary arterial hypertension.
Feldman J; Im Y; Gill K
Expert Rev Clin Pharmacol; 2015 Jan; 8(1):55-60. PubMed ID: 25409915
[TBL] [Abstract][Full Text] [Related]
12. Treprostinil: new drug. Pulmonary artery hypertension: just another (disappointing) prostacycline analogue.
Prescrire Int; 2006 Oct; 15(85):177-9. PubMed ID: 17128524
[TBL] [Abstract][Full Text] [Related]
13. Transition from intravenous or subcutaneous prostacyclin therapy to inhaled treprostinil in patients with pulmonary arterial hypertension: a retrospective case series.
Enderby CY; Soukup M; Al Omari M; Zeiger T; Burger C
J Clin Pharm Ther; 2014 Oct; 39(5):496-500. PubMed ID: 24806480
[TBL] [Abstract][Full Text] [Related]
14. Oral treprostinil in the treatment of pulmonary arterial hypertension.
Feldman J; Habib N; Radosevich J; Dutt M
Expert Opin Pharmacother; 2017 Oct; 18(15):1661-1667. PubMed ID: 28922964
[TBL] [Abstract][Full Text] [Related]
15. Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension: long-term efficacy and combination with bosentan.
Benza RL; Rayburn BK; Tallaj JA; Pamboukian SV; Bourge RC
Chest; 2008 Jul; 134(1):139-45. PubMed ID: 18403673
[TBL] [Abstract][Full Text] [Related]
16. Conversion to bosentan from prostacyclin infusion therapy in pulmonary arterial hypertension: a pilot study.
Steiner MK; Preston IR; Klinger JR; Criner GJ; Waxman AB; Farber HW; Hill NS
Chest; 2006 Nov; 130(5):1471-80. PubMed ID: 17099026
[TBL] [Abstract][Full Text] [Related]
17. Rapid Switch From Subcutaneous to Intravenous Treprostinil in Precapillary Pulmonary Hypertension by Pump Implantation.
Steringer-Mascherbauer R; Maria L; Reinhold F; Elisabeth S; Charlotte H; Dagmar E; Uwe F; Josef A
J Cardiovasc Pharmacol; 2021 Jan; 77(1):38-42. PubMed ID: 33079830
[TBL] [Abstract][Full Text] [Related]
18. Staggered transition to epoprostenol from treprostinil in pulmonary arterial hypertension.
Reisbig KA; Coffman PA; Floreani AA; Bultsma CJ; Olsen KM
Ann Pharmacother; 2005 Apr; 39(4):739-43. PubMed ID: 15755791
[TBL] [Abstract][Full Text] [Related]
19. Cost effectiveness of prostacyclins in pulmonary arterial hypertension.
Roman A; Barberà JA; Escribano P; Sala ML; Febrer L; Oyagüez I; Sabater E; Casado MA
Appl Health Econ Health Policy; 2012 May; 10(3):175-88. PubMed ID: 22452448
[TBL] [Abstract][Full Text] [Related]
20. Treprostinil for the treatment of pulmonary hypertension.
Skoro-Sajer N; Lang I
Expert Opin Pharmacother; 2008 Jun; 9(8):1415-20. PubMed ID: 18473715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]